How they use Nebius AI Cloud
Helical trained Helix-mRNA on Nebius AI Cloud and uses the infrastructure to adapt biological foundation models to specific datasets. Its virtual research tools help scientists explore DNA, RNA and single-cell data. Its Virtual AI Labs let pharma and biotech teams scale virtual experiments in hours rather than months. Helix-mRNA captures long-range biological signals and can be quickly adapted to proprietary data. The platform supports target discovery, patient stratification and RNA design using single-cell, RNA and DNA foundation models. Nebius clusters, low-latency connectivity and integrated file storage support distributed training and model alignment.
Base pretraining of the 500-million-parameter model used 16 GPUs and took 10 days. Training drew on mRNA sequences from viruses, plants, fungi, humans and other animals. Specialization runs for human sequences and other biological groups took 36 hours each. Helix-mRNA combines Mamba-2, MLP and attention layers, uses codon-aware tokenization and handles sequences up to 16,384 tokens. The customer story reports a 146% improvement in predictive accuracy for paired mRNA-ribosome measurements and a 52.5% improvement in mRNA half-life correlation compared with previous versions.
Helical shared Nebius’s account of how their work together helped scale models and accelerate customer experiments. Nebius also reports that Helical delivers in-silico tools in weeks rather than months. The customer story describes plans to expand post-training capabilities and develop a larger next-generation Helix-mRNA model.
Sources
3 sourcesNebius healthcare use-case page
24 Sept 2026 · Nebius · Web page
Nebius says Helical relies on it to pretrain and post-train the 500-million-parameter Helix-mRNA model. Helical’s Virtual AI Labs let pharma and biotech teams scale virtual experiments in hours rather than months. Helix-mRNA captures long-range biological signals and can be quickly adapted to proprietary data. Nebius reports 10-day base training, 36-hour specialization runs and delivery of in-silico tools in weeks rather than months.
Open original sourceHelical discusses scaling its biological models and experiments with Nebius
27 Jun 2025 · Helical · Web page
Helical shares Nebius’s account of working together to scale biological models and accelerate customer experiments. The account describes Helical’s use of single-cell, RNA and DNA foundation models for target discovery, patient stratification and RNA design.
Open original sourceCompany context
helical.bioHelical develops software that helps pharmaceutical and biotechnology research teams use biological foundation models in drug discovery. Its platform combines a Virtual Lab for biologists and translational scientists with a Model Factory for machine learning engineers and data scientists. Teams can evaluate models, adapt them to proprietary disease data, run computational experiments, and rank drug targets and biomarker candidates for experimental follow-up. The shared environment connects model development with scientific workflows, including target identification, biomarker discovery, patient stratification and RNA therapy design.
Helical; redalpine portfolioRecent updates
1 updateHelical raises $10 million seed round
Helical announced a $10 million seed round to build a virtual AI lab for drug discovery.
Helical GlobeNewswire release